Serum oxidative stress markers and lipidomic profile to detect NASH patients responsive to an antioxidant treatment: A pilot study

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Stiuso, Paola ^a   Scognamiglio, Ilaria ^a   Murolo, Marianna ^a   Ferranti, Pasquale ^b   De Simone, Carmela ^b   Rizzo, Maria Rosaria ^a   Tuccillo, Concetta ^a   Caraglia, Michele ^a   Loguercio, Carmelina ^a   Federico, Alessandro ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANTS; BODY FLUIDS; FLAVONOIDS; OXIDATIVE STRESS;

ANTIOXIDANT TREATMENT; CHRONIC TREATMENT; FREE CHOLESTEROLS; LIPID COMPOSITION; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS MARKERS; PROGNOSTIC MARKERS; STATISTICAL SIGNIFICANCE;

PATIENT TREATMENT;

ACYL COENZYME A DESATURASE; ANTIOXIDANT; CATALASE; LYSOPHOSPHATIDYLCHOLINE; NITRITE; REALSIL; SILIBININ; SPHINGOMYELIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; NITRIC OXIDE; PHOSPHATIDYLCHOLINE;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; FOOD; HEPATOBLASTOMA CELL LINE; HUMAN; IN VITRO STUDY; LIPID BLOOD LEVEL; LIPID COMPOSITION; LIPID STORAGE; LIPIDOMICS; LIVER HISTOLOGY; LONG TERM CARE; MALE; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PEROXIDATION; PILOT STUDY; PROGNOSIS; SCORING SYSTEM; SPECIES; TREATMENT RESPONSE; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; DRUG EFFECTS; HEPG2 CELL LINE; LIPID METABOLISM; MASS SPECTROMETRY; METABOLISM; METABOLOMICS; NON-ALCOHOLIC FATTY LIVER DISEASE;

ADULT; ANTIOXIDANTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CATALASE; FEMALE; HEP G2 CELLS; HUMANS; LIPID METABOLISM; MALE; METABOLOMICS; NITRIC OXIDE; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS; PHOSPHATIDYLCHOLINES; PILOT PROJECTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84903592183     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/169216     Document Type: Article

References (28)

1. Cusi K., Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology 2012 142 4 711 725 2-s2.0-84859404868 10.1053/j.gastro.2012.02. 003
2. Puri P., Baillie R. A., Wiest M. M., Mirshahi F., Choudhury J., Cheung O., Sargeant C., Contos M. J., Sanyal A. J., A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 2007 46 4 1081 1090 2-s2.0-36349024819 10.1002/hep.21763 (Pubitemid 350144772)
3. Puri P., Wiest M. M., Cheung O., Mirshahi F., Sargeant C., Min H.-K., Contos M. J., Sterling R. K., Fuchs M., Zhou H., Watkins S. M., Sanyal A. J., The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology 2009 50 6 1827 1838 2-s2.0-73149094543 10.1002/hep.23229
4. Caldwell S. H., Crespo D. M., The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. Journal of Hepatology 2004 40 4 578 584 2-s2.0-1642355723 10.1016/j.jhep.2004.02.013 (Pubitemid 38367778)
5. Rolo A. P., Teodoro J. S., Palmeira C. M., Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radical Biology and Medicine 2012 52 1 59 69 2-s2.0-84655169624 10.1016/j.freeradbiomed.2011.10.003
6. Vuppalanchi R., Chalasani N., Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology 2009 49 1 306 317 2-s2.0-58949094415 10.1002/hep.22603
7. Jepsen P., Grønbæk H., Prognosis and staging of non-alcoholic fatty liver disease. British Medical Journal 2011 343, article d7302
8. Saltiel A. R., Kahn C. R., Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001 414 6865 799 806 2-s2.0-0035856949 10.1038/414799a (Pubitemid 34000783)
9. Malhi H., Bronk S. F., Werneburg N. W., Gores G. J., Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. Journal of Biological Chemistry 2006 281 17 12093 12101 2-s2.0-33744948514 10.1074/jbc.M510660200 (Pubitemid 43855473)
10. Li Z., Berk M., McIntyre T. M., Gores G. J., Feldstein A. E., The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity. Hepatology 2008 47 5 1495 1503 2-s2.0-43949108922 10.1002/hep.22183 (Pubitemid 351702733)
11. Serviddio G., Bellanti F., Tamborra R., Rollo T., Romano A. D., Giudetti A. M., Capitanio N., Petrella A., Vendemiale G., Altomare E., Alterations of hepatic ATP homeostasis and respiratory chain during development of non-alcoholic steatohepatitis in a rodent model. European Journal of Clinical Investigation 2008 38 4 245 252 2-s2.0-40749091283 10.1111/j.1365-2362.2008. 01936.x (Pubitemid 351389142)
12. Araya J., Rodrigo R., Videla L. A., Thielemann L., Orellana M., Pettinelli P., Poniachik J., Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clinical Science 2004 106 6 635 643 2-s2.0-2942706241 10.1042/CS20030326 (Pubitemid 38797577)
13. Federico A., Trappoliere M., Loguercio C., Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives. Digestive and Liver Disease 2006 38 11 789 801 2-s2.0-33748946051 10.1016/j.dld.2006.04.009 (Pubitemid 44430923)
14. Salamone F., Galvano F., Cappello F., Mangiameli A., Barbagallo I., li Volti G., Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis. Translational Research 2012 159 6 477 486 2-s2.0-84861603829 10.1016/j.trsl.2011.12.003
15. Salamone F., Galvano F., Marino Gammazza A., Paternostro C., Tibullo D., Bucchieri F., Mangiamelia A., Parola M., Bugianesi E., Li Volti G., Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis. Digestive and Liver Disease 2012 44 334 342
16. Loguercio C., Andreone P., Brisc C., Brisc M. C., Bugianesi E., Chiaramonte M., Cursaro C., Danila M., De Sio I., Floreani A., Freni M. A., Grieco A., Groppo M., Lazzari R., Lobello S., Lorefice E., Margotti M., Miele L., Milani S., Okolicsanyi L., Palasciano G., Portincasa P., Saltarelli P., Smedile A., Somalvico F., Spadaro A., Sporea I., Sorrentino P., Vecchione R., Tuccillo C., Blanco C. D. V., Federico A., Silybin combined with phosphatidylcholine and vitamin e in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Free Radical Biology and Medicine 2012 52 9 1658 1665 2-s2.0-84858959526 10.1016/j.freeradbiomed.2012.02.008
17. Kleiner D. E., Brunt E. M., van Natta M., Behling C., Contos M. J., Cummings O. W., Ferrell L. D., Liu Y.-C., Torbenson M. S., Unalp-Arida A., Yeh M., McCullough A. J., Sanyal A. J., Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005 41 6 1313 1321 2-s2.0-20044374023 10.1002/hep.20701 (Pubitemid 40770284)
18. Brunt E. M., Nonalcoholic Steatohepatitis. Seminars in Liver Disease 2004 24 1 3 20 2-s2.0-1942454793 10.1055/s-2004-823098 (Pubitemid 38496045)
19. Dittmer J. C., Weus M. A., Lowenstein J. M., Quantitative and qualitative analysis of lipids and lipid components. Methods in Enzymology 1969 14 New York, NY, USA Academic Press Inc. 482 487
20. Ohkawa H., Ohishi N., Yagi K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 1979 95 2 351 358 2-s2.0-0018384650 (Pubitemid 9194347)
21. Helaleh M. I. H., Korenaga T., Ion chromatographic method for simultaneous determination of nitrate and nitrite in human saliva. Journal of Chromatography B: Biomedical Sciences and Applications 2000 744 2 433 437 2-s2.0-0034698255 10.1016/S0378-4347(00)00264-4 (Pubitemid 30456324)
22. Wheeler C. R., Salzman J. A., Elsayed N. M., Omaye S. T., Korte D. W. Jr., Automated assays for superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase activity. Analytical Biochemistry 1990 184 2 193 199 2-s2.0-0025093631 (Pubitemid 20055611)
23. Mantena S. K., King A. L., Andringa K. K., Eccleston H. B., Bailey S. M., Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radical Biology & Medicine 2008 44 7 1259 1272 2-s2.0-40949141493 10.1016/j.freeradbiomed.2007.12.029
24. Bugianesi E., McCullough A. J., Marchesini G., Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 2005 42 5 987 1000 2-s2.0-30944455145 10.1002/hep.20920 (Pubitemid 43112663)
25. Cui W., Chen S. L., Hu K.-Q., Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells. The American Journal of Translational Research 2010 2 1 95 104 2-s2.0-77953391746
26. Huitema K., van den Dikkenberg J., Brouwers J. F. H. M., Holthuis J. C. M., Identification of a family of animal sphingomyelin synthases. The EMBO Journal 2004 23 1 33 44 2-s2.0-0842263750 10.1038/sj.emboj.7600034 (Pubitemid 38165745)
27. Burger K. N. J., van der Bijl P., van Meer G., Topology of sphingolipid galactosyltransferases in ER and Golgi: transbilayer movement of monohexosyl sphingolipids is required for higher glycosphingolipid biosynthesis. Journal of Cell Biology 1996 133 1 15 28 2-s2.0-0029931962 10.1083/jcb.133.1.15 (Pubitemid 26107092)
28. Seijiro H., Tsutomu S., Nobuo T., Takuji M., Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells. Arteriosclerosis, Thrombosis, and Vascular Biology 1997 17 1258 1266 10.1161/01.ATV.17.7.1258